Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GENTA IND FOR LEUKEMIA TREATMENT

Aug. 28, 1991

SYNERGEN STOCK CONTINUES TO RISE

Aug. 28, 1991

RECEPTECH CANCELS IL-8 PROJECT

Aug. 28, 1991

DOCTORS FACE DILEMMA WITH SEPSIS DRUGS

Aug. 28, 1991

GENPHARM PRODUCES TRANSGENIC DAIRY CALF

Aug. 27, 1991

ALKERMES IND FOR BLOOD-BRAIN DELIVERY

Aug. 27, 1991

AIS TO TEST CELLECTOR ON STEM CELLS

Aug. 27, 1991

BTGC NETS $3.1 MILLION IN PRIVATE PLACEMENT

Aug. 27, 1991

SYNTHETECH COMPLETES $1 MILLION PLACEMENT

Aug. 27, 1991

IMMUNE RESPONSE RIDES ANALYST RECOMMENDATION

Aug. 27, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...